CapMan is expanding its life science business unit in Finland and Denmark with the appointment of Dr Björn Nordenvall. Nordenvall previously worked as managing director for Sophiahemmet AB and biotechnology company Oxigene Inc.
;It is stimulating for CapMan to be able to invest in our life science unit also during weaker market conditions. The expansion strengthens our ambitious goals in life science and is proof of CapMan’s strong financial position,” says Jan Lundahl, head of CapMan’s life science business unit with over 15 years’ experience in the industry.
The life science business unit is currently based in Sweden, but its operations will be expanding to Finland and Denmark and as part of this expansion further new recruits will be taken on board.